Neurogene (NGNE) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to -$0.99.
- Neurogene's EPS (Weighted Average and Diluted) rose 1680.67% to -$0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.11, marking a year-over-year decrease of 107428.57%. This contributed to the annual value of -$4.31 for FY2024, which is 24708.32% down from last year.
- Latest data reveals that Neurogene reported EPS (Weighted Average and Diluted) of -$0.99 as of Q3 2025, which was up 1680.67% from -$1.05 recorded in Q2 2025.
- In the past 5 years, Neurogene's EPS (Weighted Average and Diluted) ranged from a high of $2.93 in Q4 2023 and a low of -$32.67 during Q3 2023
- Over the past 3 years, Neurogene's median EPS (Weighted Average and Diluted) value was -$1.09 (recorded in 2024), while the average stood at -$8.38.
- Within the past 5 years, the most significant YoY rise in Neurogene's EPS (Weighted Average and Diluted) was 9646.39% (2024), while the steepest drop was 13818.81% (2024).
- Over the past 3 years, Neurogene's EPS (Weighted Average and Diluted) (Quarter) stood at $2.93 in 2023, then crashed by 138.19% to -$1.12 in 2024, then increased by 11.52% to -$0.99 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.99 for Q3 2025, versus -$1.05 for Q2 2025 and -$1.08 for Q1 2025.